Deptula Peter, McCullough Meghan, Brown Theodore, Singh Dylan, Kuschner Stuart, Kulber David
From the Department of Hand Surgery, Cedars-Sinai Medical Center, Los Angeles, Calif.
Division of Plastic and Reconstructive Surgery, Stanford University, Stanford, Calif.
Plast Reconstr Surg Glob Open. 2024 Oct 3;12(10):e6205. doi: 10.1097/GOX.0000000000006205. eCollection 2024 Oct.
Scaphocapitate arthrodesis (SCA) is a described technique for chronic wrist pathology such as Kienbock disease and carpal instability. The technique aims to preserve motion, while maintaining carpal height, preserving the radioscaphoid articulation, and offloading the lunate. Limited case series evaluate the outcomes of this previously described technique. We aim to determine if the collective, updated literature on outcomes of SCA support its continued application by the wrist surgeon. Furthermore, we investigated if any technical variations offer an advantage in improving patient-reported outcomes after SCA.
A literature search was performed using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Articles selected for critical review were examined for patient demographic data, functional outcomes, radiographic outcomes, and complications. A qualitative analysis was then performed to synthesize the available date.
A total of 18 unique articles published between 1991 and 2022 were identified, representing a total of 285 individual cases of SCA. Nonunion rate ranged 0%-22%. Preoperative visual analog scale pain scores ranged from 3.2 to 10, whereas postoperative visual analog scale pain scores ranged from 0 to 4. Patient-reported outcomes are reported by validated instruments, including the Disabilities of the Arm, Shoulder, and Hand, QuickDASH, Patient-rated Wrist Evaluation, and Mayo Wrist Score.
SCA is a viable treatment option for patients with Kienbock disease. SCA offers reliable improvements in patient pain, grip strength, and patient-reported outcomes.
舟月关节融合术(SCA)是一种针对诸如月骨无菌性坏死和腕骨不稳等慢性腕部疾病的技术。该技术旨在保留活动度,同时维持腕骨高度,保留桡舟关节,并减轻月骨的负荷。有限的病例系列评估了这种先前描述的技术的疗效。我们旨在确定关于SCA疗效的综合、更新文献是否支持腕关节外科医生继续应用该技术。此外,我们调查了是否有任何技术变体在改善SCA术后患者报告的疗效方面具有优势。
按照系统评价和Meta分析的首选报告项目指南进行文献检索。对选定进行严格审查的文章,检查其患者人口统计学数据、功能结局、影像学结局和并发症。然后进行定性分析以综合现有数据。
共确定了1991年至2022年间发表的18篇独特文章,代表了总共285例SCA个体病例。骨不连发生率在0%至22%之间。术前视觉模拟量表疼痛评分范围为3.2至10,而术后视觉模拟量表疼痛评分范围为0至4。患者报告的结局通过经过验证的工具报告,包括手臂、肩部和手部功能障碍量表、快速残疾评定量表、患者自评腕关节评估量表和梅奥腕关节评分量表。
SCA是月骨无菌性坏死患者的一种可行治疗选择。SCA在患者疼痛、握力和患者报告的结局方面提供了可靠的改善。